Atlas Trials

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

Clinical trial NCT06686381 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06686381
Sponsor
American University of Beirut Medical Center
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Muscle-invasive Bladder Cancer
Start date
2025-04-15
Primary completion
2028-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.